| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 36 |
| 1 | ALBUTEROL SULFATE | 34 |
| 2 | FUROSEMIDE | 33 |
| 3 | NINTEDANIB | 33 |
| 4 | RIVAROXABAN | 27 |
| 5 | VALSARTAN | 27 |
| 6 | IRBESARTAN | 26 |
| 7 | SPIRONOLACTONE | 26 |
| 8 | VALSARTAN ORAL | 26 |
| 9 | TREPROSTINIL | 24 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CROMOLYN SODIUM | 6 | 0.0016 |
| 1 | CLINDAMYCIN PHOSPHATE | 6 | 0.0011 |
| 2 | NINTEDANIB | 33 | 0.0010 |
| 3 | ETOMIDATE INJECTION | 2 | 0.0009 |
| 4 | ETOMIDATE | 2 | 0.0009 |
| 5 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 4 | 0.0009 |
| 6 | INFLIXIMAB-DYYB | 3 | 0.0009 |
| 7 | ERGOCALCIFEROL | 22 | 0.0007 |
| 8 | IRBESARTAN | 26 | 0.0006 |
| 9 | CLINDAMYCIN HYDROCHLORIDE | 2 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 58 |
| 1 | HMG-CoA Reductase Inhibitor [EPC] | 42 |
| 2 | Loop Diuretic [EPC] | 41 |
| 3 | Angiotensin 2 Receptor Blocker [EPC] | 40 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 40 |
| 5 | Endothelin Receptor Antagonist [EPC] | 35 |
| 6 | Factor Xa Inhibitor [EPC] | 31 |
| 7 | Aldosterone Antagonist [EPC] | 28 |
| 8 | Prostacycline Vasodilator [EPC] | 25 |
| 9 | Provitamin D2 Compound [EPC] | 22 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 17 | 0.0247 |
| 1 | Vasoconstrictor [EPC] | 1 | 0.0033 |
| 2 | Surfactant [EPC] | 2 | 0.0017 |
| 3 | Interleukin-6 Antagonist [EPC] | 1 | 0.0015 |
| 4 | Human alpha-1 Proteinase Inhibitor [EPC] | 4 | 0.0009 |
| 5 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 1 | 0.0008 |
| 6 | Provitamin D2 Compound [EPC] | 22 | 0.0007 |
| 7 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 8 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |
| 9 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |